These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 25589277)

  • 1. [Post-injection syndrome after depot injection of olanzapine].
    Wilms EB; van der Velden MT; van Essen FH; ten Brink C
    Ned Tijdschr Geneeskd; 2014; 159():A7885. PubMed ID: 25589277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Post-injection delirium/sedation syndrome following injection of olanzapine pamoate: a new syndrome in emergency psychiatry].
    Buts K; Van Hecke J
    Tijdschr Psychiatr; 2014; 56(4):273-6. PubMed ID: 24807388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Olanzapine pamoate for the treatment of schizophrenia.
    Naber D
    Expert Opin Pharmacother; 2011 Mar; 12(4):627-33. PubMed ID: 21254860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-injection delirium/sedation syndrome in patients with schizophrenia treated with olanzapine long-acting injection, II: investigations of mechanism.
    McDonnell DP; Detke HC; Bergstrom RF; Kothare P; Johnson J; Stickelmeyer M; Sanchez-Felix MV; Sorsaburu S; Mitchell MI
    BMC Psychiatry; 2010 Jun; 10():45. PubMed ID: 20537130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Olanzapine: a review of rapid and long-acting parenteral formulations.
    Owen RT
    Drugs Today (Barc); 2010 Mar; 46(3):173-81. PubMed ID: 20467591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-injection delirium/sedation syndrome in patients with schizophrenia treated with olanzapine long-acting injection, I: analysis of cases.
    Detke HC; McDonnell DP; Brunner E; Zhao F; Sorsaburu S; Stefaniak VJ; Corya SA
    BMC Psychiatry; 2010 Jun; 10():43. PubMed ID: 20537128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single- and multiple-dose pharmacokinetic, safety, and tolerability profiles of olanzapine long-acting injection: an open-label, multicenter, nonrandomized study in patients with schizophrenia.
    Mitchell M; Kothare P; Bergstrom R; Zhao F; Jen KY; Walker D; Johnson J; McDonnell D
    Clin Ther; 2013 Dec; 35(12):1890-908. PubMed ID: 24184052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug safety evaluation of olanzapine pamoate.
    Schöttle D; Kuhnigk O; Naber D
    Expert Opin Drug Saf; 2013 Nov; 12(6):897-903. PubMed ID: 24024627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pooled analysis of injection site-related adverse events in patients with schizophrenia treated with olanzapine long-acting injection.
    Atkins S; Detke HC; McDonnell DP; Case MG; Wang S
    BMC Psychiatry; 2014 Jan; 14():7. PubMed ID: 24423017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Olanzapine long-acting injection: a review of its use in the treatment of schizophrenia.
    Frampton JE
    Drugs; 2010 Dec; 70(17):2289-313. PubMed ID: 21080745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Follow-up study of patients treated with olanzapine pamoate in France in real-life treatment situation.
    Chartier F; Rouillon F; Berggren L; Jamonneau I; Falissard B; Llorca PM
    Encephale; 2017 Aug; 43(4):303-310. PubMed ID: 28709669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-Injection Delirium/Sedation Syndrome after Olanzapine Long-Acting Intramuscular Injection - Who is at Risk?
    Łukasik-Głębocka M; Sommerfeld K; Teżyk A; Panieński P; Żaba C; Zielińska-Psuja B
    Basic Clin Pharmacol Toxicol; 2015 Sep; 117(3):213-4. PubMed ID: 25703610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intramuscular olanzapine versus intramuscular haloperidol plus lorazepam for the treatment of acute schizophrenia with agitation: An open-label, randomized controlled trial.
    Huang CL; Hwang TJ; Chen YH; Huang GH; Hsieh MH; Chen HH; Hwu HG
    J Formos Med Assoc; 2015 May; 114(5):438-45. PubMed ID: 25791540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Olanzapine long-acting injection: a 24-week, randomized, double-blind trial of maintenance treatment in patients with schizophrenia.
    Kane JM; Detke HC; Naber D; Sethuraman G; Lin DY; Bergstrom RF; McDonnell D
    Am J Psychiatry; 2010 Feb; 167(2):181-9. PubMed ID: 20008947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Baseline characteristics and hospitalizations in patients with schizophrenia receiving olanzapine long-acting injection: an interim analysis from a non-interventional, prospective observational safety study.
    Jones ME; Andrews JS; Faries DE; Landry J; Xu J; Detke HC; Chhabra-Khanna R; McDonnell DP
    BMC Psychiatry; 2015 Nov; 15():278. PubMed ID: 26567159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Olanzapine pamoate for the treatment of schizophrenia--a safety evaluation.
    Samalin L; Garay R; Ameg A; Llorca PM
    Expert Opin Drug Saf; 2016; 15(3):403-11. PubMed ID: 26761429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Post-injection syndrome and olanzapine pamoate: A severe case report].
    Descusse A; Chebili S; Artiges E
    Encephale; 2017 Aug; 43(4):405. PubMed ID: 27349579
    [No Abstract]   [Full Text] [Related]  

  • 18. [Olanzapine long-acting post-injection syndrome: a case report and brief review].
    Duran-Sindreu SF; Grasa-Bello E; Corripio-Collado I; Sauras-Quetcuti RB; Keymer-Gausset A; Roldán-Bejarano A; Alonso-Solís A; Figueras-Vilalta M; Álvarez-Martínez E
    Actas Esp Psiquiatr; 2013; 41(1):60-2. PubMed ID: 23440537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Olanzapine pamoate: a stick in time? A review of the efficacy and safety profile of a new depot formulation of a second-generation antipsychotic.
    Citrome L
    Int J Clin Pract; 2009 Jan; 63(1):140-50. PubMed ID: 18834452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intramuscular olanzapine vs. intramuscular short-acting antipsychotics: safety, tolerability and the switch to oral antipsychotic medication in patients with schizophrenia or acute mania.
    Chandrasena R; Dvoráková D; Lee SI; Loza N; Mosolov SN; Osváth P; Pregelj P; Walton RJ; Karagianis J; Treuer T
    Int J Clin Pract; 2009 Aug; 63(8):1249-58. PubMed ID: 19558486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.